nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—Emtricitabine—Floxuridine—stomach cancer	0.336	0.761	CrCrCtD
Lamivudine—Decitabine—Floxuridine—stomach cancer	0.106	0.239	CrCrCtD
Lamivudine—ABCC3—Fluorouracil—stomach cancer	0.0302	0.0917	CbGbCtD
Lamivudine—SLC22A3—Irinotecan—stomach cancer	0.0296	0.0899	CbGbCtD
Lamivudine—ABCC4—Fluorouracil—stomach cancer	0.0231	0.0701	CbGbCtD
Lamivudine—ABCC1—Epirubicin—stomach cancer	0.0199	0.0603	CbGbCtD
Lamivudine—ABCC1—Irinotecan—stomach cancer	0.0193	0.0587	CbGbCtD
Lamivudine—ABCB1—Mitomycin—stomach cancer	0.0182	0.0552	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—stomach cancer	0.0172	0.0522	CbGbCtD
Lamivudine—ABCC3—Methotrexate—stomach cancer	0.0166	0.0506	CbGbCtD
Lamivudine—ABCC2—Irinotecan—stomach cancer	0.0143	0.0434	CbGbCtD
Lamivudine—ABCC1—Docetaxel—stomach cancer	0.0142	0.043	CbGbCtD
Lamivudine—ABCG2—Irinotecan—stomach cancer	0.0129	0.0393	CbGbCtD
Lamivudine—ABCC4—Methotrexate—stomach cancer	0.0127	0.0386	CbGbCtD
Lamivudine—ABCG2—Fluorouracil—stomach cancer	0.0124	0.0377	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—stomach cancer	0.0106	0.0321	CbGbCtD
Lamivudine—ABCC2—Docetaxel—stomach cancer	0.0105	0.0318	CbGbCtD
Lamivudine—ABCC1—Methotrexate—stomach cancer	0.0102	0.0311	CbGbCtD
Lamivudine—ABCG2—Docetaxel—stomach cancer	0.00947	0.0288	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—stomach cancer	0.00781	0.0237	CbGbCtD
Lamivudine—ABCC2—Methotrexate—stomach cancer	0.00757	0.023	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—stomach cancer	0.00706	0.0215	CbGbCtD
Lamivudine—ABCG2—Methotrexate—stomach cancer	0.00684	0.0208	CbGbCtD
Lamivudine—SLC22A6—Methotrexate—stomach cancer	0.00554	0.0168	CbGbCtD
Lamivudine—ABCB1—Irinotecan—stomach cancer	0.00466	0.0142	CbGbCtD
Lamivudine—ABCB1—Docetaxel—stomach cancer	0.00342	0.0104	CbGbCtD
Lamivudine—ABCB1—Doxorubicin—stomach cancer	0.00255	0.00774	CbGbCtD
Lamivudine—ABCB1—Methotrexate—stomach cancer	0.00247	0.00749	CbGbCtD
Lamivudine—ABCC2—bile—stomach cancer	0.00233	0.0447	CbGeAlD
Lamivudine—PGK1—hematopoietic system—stomach cancer	0.00189	0.0361	CbGeAlD
Lamivudine—NME1-NME2—hematopoietic system—stomach cancer	0.00172	0.0329	CbGeAlD
Lamivudine—NT5C—hematopoietic system—stomach cancer	0.00159	0.0305	CbGeAlD
Lamivudine—PCYT2—digestive system—stomach cancer	0.00153	0.0292	CbGeAlD
Lamivudine—PCYT1A—hematopoietic system—stomach cancer	0.00149	0.0286	CbGeAlD
Lamivudine—PGK1—digestive system—stomach cancer	0.00131	0.0251	CbGeAlD
Lamivudine—PCYT2—endocrine gland—stomach cancer	0.00126	0.0242	CbGeAlD
Lamivudine—Cytarabine—NT5E—stomach cancer	0.00122	0.466	CrCbGaD
Lamivudine—PCYT2—liver—stomach cancer	0.00114	0.0218	CbGeAlD
Lamivudine—NT5C—lymphoid tissue—stomach cancer	0.00112	0.0215	CbGeAlD
Lamivudine—DCK—Topotecan—Irinotecan—stomach cancer	0.00109	0.688	CbGdCrCtD
Lamivudine—PGK1—endocrine gland—stomach cancer	0.00108	0.0208	CbGeAlD
Lamivudine—PCYT1A—digestive system—stomach cancer	0.00104	0.0199	CbGeAlD
Lamivudine—NME1—hematopoietic system—stomach cancer	0.000999	0.0191	CbGeAlD
Lamivudine—NME1-NME2—endocrine gland—stomach cancer	0.000987	0.0189	CbGeAlD
Lamivudine—PGK1—liver—stomach cancer	0.000977	0.0187	CbGeAlD
Lamivudine—CMPK1—hematopoietic system—stomach cancer	0.000963	0.0184	CbGeAlD
Lamivudine—Decitabine—DNMT1—stomach cancer	0.000957	0.366	CrCbGaD
Lamivudine—NME2—hematopoietic system—stomach cancer	0.000941	0.018	CbGeAlD
Lamivudine—NT5C—endocrine gland—stomach cancer	0.000915	0.0175	CbGeAlD
Lamivudine—NME1-NME2—liver—stomach cancer	0.00089	0.017	CbGeAlD
Lamivudine—NME2—epithelium—stomach cancer	0.00086	0.0165	CbGeAlD
Lamivudine—PCYT1A—endocrine gland—stomach cancer	0.000859	0.0164	CbGeAlD
Lamivudine—CMPK1—smooth muscle tissue—stomach cancer	0.000848	0.0162	CbGeAlD
Lamivudine—NT5C—liver—stomach cancer	0.000825	0.0158	CbGeAlD
Lamivudine—ABCC3—gall bladder—stomach cancer	0.000811	0.0155	CbGeAlD
Lamivudine—CMPK1—pancreas—stomach cancer	0.000784	0.015	CbGeAlD
Lamivudine—PCYT1A—liver—stomach cancer	0.000774	0.0148	CbGeAlD
Lamivudine—NME2—pancreas—stomach cancer	0.000766	0.0147	CbGeAlD
Lamivudine—NME1—lymphoid tissue—stomach cancer	0.000703	0.0135	CbGeAlD
Lamivudine—NME1—digestive system—stomach cancer	0.000695	0.0133	CbGeAlD
Lamivudine—NME1-NME2—lymph node—stomach cancer	0.000682	0.0131	CbGeAlD
Lamivudine—CMPK1—lymphoid tissue—stomach cancer	0.000678	0.013	CbGeAlD
Lamivudine—CMPK1—digestive system—stomach cancer	0.00067	0.0128	CbGeAlD
Lamivudine—NME2—lymphoid tissue—stomach cancer	0.000663	0.0127	CbGeAlD
Lamivudine—NME2—digestive system—stomach cancer	0.000654	0.0125	CbGeAlD
Lamivudine—NME1—bone marrow—stomach cancer	0.00064	0.0123	CbGeAlD
Lamivudine—NT5C—lymph node—stomach cancer	0.000633	0.0121	CbGeAlD
Lamivudine—CMPK1—bone marrow—stomach cancer	0.000617	0.0118	CbGeAlD
Lamivudine—NME1—endocrine gland—stomach cancer	0.000574	0.011	CbGeAlD
Lamivudine—CMPK1—endocrine gland—stomach cancer	0.000553	0.0106	CbGeAlD
Lamivudine—NME2—endocrine gland—stomach cancer	0.000541	0.0104	CbGeAlD
Lamivudine—NME1—liver—stomach cancer	0.000518	0.00992	CbGeAlD
Lamivudine—CMPK1—liver—stomach cancer	0.000499	0.00956	CbGeAlD
Lamivudine—NME2—liver—stomach cancer	0.000488	0.00934	CbGeAlD
Lamivudine—DCK—hematopoietic system—stomach cancer	0.000479	0.00918	CbGeAlD
Lamivudine—ABCC3—hematopoietic system—stomach cancer	0.000459	0.00879	CbGeAlD
Lamivudine—Gemcitabine—TYMS—stomach cancer	0.000441	0.169	CrCbGaD
Lamivudine—SLC22A2—digestive system—stomach cancer	0.000403	0.00771	CbGeAlD
Lamivudine—NME1—lymph node—stomach cancer	0.000397	0.0076	CbGeAlD
Lamivudine—SLC22A3—hematopoietic system—stomach cancer	0.000391	0.00749	CbGeAlD
Lamivudine—DCK—pancreas—stomach cancer	0.00039	0.00748	CbGeAlD
Lamivudine—CMPK1—lymph node—stomach cancer	0.000382	0.00733	CbGeAlD
Lamivudine—ABCC4—hematopoietic system—stomach cancer	0.000379	0.00726	CbGeAlD
Lamivudine—NME2—lymph node—stomach cancer	0.000374	0.00716	CbGeAlD
Lamivudine—SLC22A3—smooth muscle tissue—stomach cancer	0.000344	0.00659	CbGeAlD
Lamivudine—DCK—lymphoid tissue—stomach cancer	0.000338	0.00647	CbGeAlD
Lamivudine—DCK—digestive system—stomach cancer	0.000333	0.00639	CbGeAlD
Lamivudine—ABCC3—digestive system—stomach cancer	0.000319	0.00611	CbGeAlD
Lamivudine—ABCC4—pancreas—stomach cancer	0.000309	0.00591	CbGeAlD
Lamivudine—DCK—bone marrow—stomach cancer	0.000307	0.00589	CbGeAlD
Lamivudine—DCK—endocrine gland—stomach cancer	0.000276	0.00528	CbGeAlD
Lamivudine—ABCC3—endocrine gland—stomach cancer	0.000264	0.00505	CbGeAlD
Lamivudine—ABCC4—digestive system—stomach cancer	0.000264	0.00505	CbGeAlD
Lamivudine—DCK—Doxorubicin—Epirubicin—stomach cancer	0.000256	0.162	CbGdCrCtD
Lamivudine—ABCC2—digestive system—stomach cancer	0.000255	0.00489	CbGeAlD
Lamivudine—DCK—liver—stomach cancer	0.000248	0.00476	CbGeAlD
Lamivudine—ABCB1—blood vessel—stomach cancer	0.000248	0.00474	CbGeAlD
Lamivudine—ABCC4—bone marrow—stomach cancer	0.000243	0.00465	CbGeAlD
Lamivudine—ABCC3—liver—stomach cancer	0.000238	0.00456	CbGeAlD
Lamivudine—DCK—Epirubicin—Doxorubicin—stomach cancer	0.000237	0.15	CbGdCrCtD
Lamivudine—SLC22A1—endocrine gland—stomach cancer	0.000235	0.0045	CbGeAlD
Lamivudine—SLC22A3—endocrine gland—stomach cancer	0.000225	0.0043	CbGeAlD
Lamivudine—ABCC4—endocrine gland—stomach cancer	0.000218	0.00417	CbGeAlD
Lamivudine—SLC22A1—liver—stomach cancer	0.000212	0.00406	CbGeAlD
Lamivudine—ABCC2—endocrine gland—stomach cancer	0.000211	0.00404	CbGeAlD
Lamivudine—SLC22A3—liver—stomach cancer	0.000202	0.00388	CbGeAlD
Lamivudine—ABCC4—liver—stomach cancer	0.000196	0.00376	CbGeAlD
Lamivudine—DCK—lymph node—stomach cancer	0.00019	0.00365	CbGeAlD
Lamivudine—ABCC2—liver—stomach cancer	0.00019	0.00364	CbGeAlD
Lamivudine—ABCC3—lymph node—stomach cancer	0.000182	0.00349	CbGeAlD
Lamivudine—ABCG2—bone marrow—stomach cancer	0.000171	0.00328	CbGeAlD
Lamivudine—ABCC1—liver—stomach cancer	0.000167	0.00321	CbGeAlD
Lamivudine—SLC22A3—lymph node—stomach cancer	0.000155	0.00297	CbGeAlD
Lamivudine—ABCC4—lymph node—stomach cancer	0.000151	0.00288	CbGeAlD
Lamivudine—ABCC2—lymph node—stomach cancer	0.000146	0.00279	CbGeAlD
Lamivudine—ABCG2—liver—stomach cancer	0.000139	0.00265	CbGeAlD
Lamivudine—ABCB1—hematopoietic system—stomach cancer	0.000132	0.00253	CbGeAlD
Lamivudine—ABCC1—lymph node—stomach cancer	0.000128	0.00246	CbGeAlD
Lamivudine—ABCB1—epithelium—stomach cancer	0.000121	0.00231	CbGeAlD
Lamivudine—ABCB1—pancreas—stomach cancer	0.000107	0.00206	CbGeAlD
Lamivudine—ABCG2—lymph node—stomach cancer	0.000106	0.00204	CbGeAlD
Lamivudine—ABCB1—lymphoid tissue—stomach cancer	9.29e-05	0.00178	CbGeAlD
Lamivudine—ABCB1—digestive system—stomach cancer	9.17e-05	0.00176	CbGeAlD
Lamivudine—ABCB1—bone marrow—stomach cancer	8.46e-05	0.00162	CbGeAlD
Lamivudine—ABCB1—endocrine gland—stomach cancer	7.58e-05	0.00145	CbGeAlD
Lamivudine—ABCB1—liver—stomach cancer	6.83e-05	0.00131	CbGeAlD
Lamivudine—Agranulocytosis—Doxorubicin—stomach cancer	5.44e-05	0.0007	CcSEcCtD
Lamivudine—Rash—Irinotecan—stomach cancer	5.44e-05	0.000699	CcSEcCtD
Lamivudine—Dermatitis—Irinotecan—stomach cancer	5.43e-05	0.000698	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Docetaxel—stomach cancer	5.43e-05	0.000698	CcSEcCtD
Lamivudine—Chills—Methotrexate—stomach cancer	5.43e-05	0.000697	CcSEcCtD
Lamivudine—Headache—Irinotecan—stomach cancer	5.4e-05	0.000694	CcSEcCtD
Lamivudine—Hypotension—Capecitabine—stomach cancer	5.39e-05	0.000693	CcSEcCtD
Lamivudine—Insomnia—Docetaxel—stomach cancer	5.39e-05	0.000693	CcSEcCtD
Lamivudine—Paraesthesia—Docetaxel—stomach cancer	5.35e-05	0.000688	CcSEcCtD
Lamivudine—Erythema multiforme—Epirubicin—stomach cancer	5.35e-05	0.000688	CcSEcCtD
Lamivudine—Alopecia—Methotrexate—stomach cancer	5.35e-05	0.000687	CcSEcCtD
Lamivudine—Dyspnoea—Docetaxel—stomach cancer	5.32e-05	0.000683	CcSEcCtD
Lamivudine—Somnolence—Docetaxel—stomach cancer	5.3e-05	0.000681	CcSEcCtD
Lamivudine—Erythema—Methotrexate—stomach cancer	5.27e-05	0.000677	CcSEcCtD
Lamivudine—Malnutrition—Methotrexate—stomach cancer	5.27e-05	0.000677	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Capecitabine—stomach cancer	5.26e-05	0.000676	CcSEcCtD
Lamivudine—Vomiting—Fluorouracil—stomach cancer	5.25e-05	0.000675	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—stomach cancer	5.25e-05	0.000675	CcSEcCtD
Lamivudine—Dyspepsia—Docetaxel—stomach cancer	5.25e-05	0.000674	CcSEcCtD
Lamivudine—ABCB1—lymph node—stomach cancer	5.24e-05	0.001	CbGeAlD
Lamivudine—Hepatitis—Doxorubicin—stomach cancer	5.24e-05	0.000673	CcSEcCtD
Lamivudine—Insomnia—Capecitabine—stomach cancer	5.22e-05	0.000671	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—stomach cancer	5.21e-05	0.00067	CcSEcCtD
Lamivudine—Rash—Fluorouracil—stomach cancer	5.21e-05	0.000669	CcSEcCtD
Lamivudine—Dermatitis—Fluorouracil—stomach cancer	5.2e-05	0.000669	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—stomach cancer	5.2e-05	0.000668	CcSEcCtD
Lamivudine—Paraesthesia—Capecitabine—stomach cancer	5.18e-05	0.000666	CcSEcCtD
Lamivudine—Decreased appetite—Docetaxel—stomach cancer	5.18e-05	0.000666	CcSEcCtD
Lamivudine—Headache—Fluorouracil—stomach cancer	5.18e-05	0.000665	CcSEcCtD
Lamivudine—Dysgeusia—Methotrexate—stomach cancer	5.16e-05	0.000663	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Docetaxel—stomach cancer	5.15e-05	0.000661	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—stomach cancer	5.15e-05	0.000661	CcSEcCtD
Lamivudine—Dyspnoea—Capecitabine—stomach cancer	5.15e-05	0.000661	CcSEcCtD
Lamivudine—Fatigue—Docetaxel—stomach cancer	5.14e-05	0.000661	CcSEcCtD
Lamivudine—Nausea—Irinotecan—stomach cancer	5.12e-05	0.000658	CcSEcCtD
Lamivudine—Immune system disorder—Epirubicin—stomach cancer	5.11e-05	0.000657	CcSEcCtD
Lamivudine—Mediastinal disorder—Epirubicin—stomach cancer	5.1e-05	0.000656	CcSEcCtD
Lamivudine—Constipation—Docetaxel—stomach cancer	5.1e-05	0.000655	CcSEcCtD
Lamivudine—Pain—Docetaxel—stomach cancer	5.1e-05	0.000655	CcSEcCtD
Lamivudine—Back pain—Methotrexate—stomach cancer	5.09e-05	0.000654	CcSEcCtD
Lamivudine—Dyspepsia—Capecitabine—stomach cancer	5.08e-05	0.000653	CcSEcCtD
Lamivudine—Chills—Epirubicin—stomach cancer	5.08e-05	0.000653	CcSEcCtD
Lamivudine—Decreased appetite—Capecitabine—stomach cancer	5.02e-05	0.000645	CcSEcCtD
Lamivudine—Alopecia—Epirubicin—stomach cancer	5e-05	0.000643	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Capecitabine—stomach cancer	4.98e-05	0.00064	CcSEcCtD
Lamivudine—Fatigue—Capecitabine—stomach cancer	4.98e-05	0.000639	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—stomach cancer	4.95e-05	0.000636	CcSEcCtD
Lamivudine—Pain—Capecitabine—stomach cancer	4.94e-05	0.000634	CcSEcCtD
Lamivudine—Constipation—Capecitabine—stomach cancer	4.94e-05	0.000634	CcSEcCtD
Lamivudine—Erythema—Epirubicin—stomach cancer	4.93e-05	0.000633	CcSEcCtD
Lamivudine—Malnutrition—Epirubicin—stomach cancer	4.93e-05	0.000633	CcSEcCtD
Lamivudine—Feeling abnormal—Docetaxel—stomach cancer	4.91e-05	0.000631	CcSEcCtD
Lamivudine—Nausea—Fluorouracil—stomach cancer	4.91e-05	0.00063	CcSEcCtD
Lamivudine—Ill-defined disorder—Methotrexate—stomach cancer	4.89e-05	0.000628	CcSEcCtD
Lamivudine—Gastrointestinal pain—Docetaxel—stomach cancer	4.88e-05	0.000626	CcSEcCtD
Lamivudine—Anaemia—Methotrexate—stomach cancer	4.87e-05	0.000625	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—stomach cancer	4.86e-05	0.000624	CcSEcCtD
Lamivudine—Tension—Epirubicin—stomach cancer	4.84e-05	0.000621	CcSEcCtD
Lamivudine—Dysgeusia—Epirubicin—stomach cancer	4.83e-05	0.00062	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—stomach cancer	4.79e-05	0.000615	CcSEcCtD
Lamivudine—Back pain—Epirubicin—stomach cancer	4.77e-05	0.000612	CcSEcCtD
Lamivudine—Feeling abnormal—Capecitabine—stomach cancer	4.76e-05	0.000611	CcSEcCtD
Lamivudine—Malaise—Methotrexate—stomach cancer	4.75e-05	0.00061	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—stomach cancer	4.74e-05	0.000609	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—stomach cancer	4.73e-05	0.000608	CcSEcCtD
Lamivudine—Vertigo—Methotrexate—stomach cancer	4.73e-05	0.000608	CcSEcCtD
Lamivudine—Gastrointestinal pain—Capecitabine—stomach cancer	4.72e-05	0.000607	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—stomach cancer	4.72e-05	0.000607	CcSEcCtD
Lamivudine—Abdominal pain—Docetaxel—stomach cancer	4.71e-05	0.000606	CcSEcCtD
Lamivudine—Body temperature increased—Docetaxel—stomach cancer	4.71e-05	0.000606	CcSEcCtD
Lamivudine—Leukopenia—Methotrexate—stomach cancer	4.71e-05	0.000606	CcSEcCtD
Lamivudine—Chills—Doxorubicin—stomach cancer	4.7e-05	0.000604	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—stomach cancer	4.63e-05	0.000595	CcSEcCtD
Lamivudine—Cough—Methotrexate—stomach cancer	4.59e-05	0.00059	CcSEcCtD
Lamivudine—Urticaria—Capecitabine—stomach cancer	4.59e-05	0.000589	CcSEcCtD
Lamivudine—Ill-defined disorder—Epirubicin—stomach cancer	4.57e-05	0.000587	CcSEcCtD
Lamivudine—Abdominal pain—Capecitabine—stomach cancer	4.56e-05	0.000586	CcSEcCtD
Lamivudine—Body temperature increased—Capecitabine—stomach cancer	4.56e-05	0.000586	CcSEcCtD
Lamivudine—Convulsion—Methotrexate—stomach cancer	4.56e-05	0.000586	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—stomach cancer	4.56e-05	0.000586	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—stomach cancer	4.56e-05	0.000586	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—stomach cancer	4.55e-05	0.000585	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—stomach cancer	4.49e-05	0.000577	CcSEcCtD
Lamivudine—Arthralgia—Methotrexate—stomach cancer	4.48e-05	0.000576	CcSEcCtD
Lamivudine—Myalgia—Methotrexate—stomach cancer	4.48e-05	0.000576	CcSEcCtD
Lamivudine—Chest pain—Methotrexate—stomach cancer	4.48e-05	0.000576	CcSEcCtD
Lamivudine—Tension—Doxorubicin—stomach cancer	4.47e-05	0.000575	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—stomach cancer	4.47e-05	0.000574	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	4.45e-05	0.000572	CcSEcCtD
Lamivudine—Malaise—Epirubicin—stomach cancer	4.44e-05	0.000571	CcSEcCtD
Lamivudine—Discomfort—Methotrexate—stomach cancer	4.43e-05	0.000569	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—stomach cancer	4.43e-05	0.000569	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—stomach cancer	4.43e-05	0.000569	CcSEcCtD
Lamivudine—Syncope—Epirubicin—stomach cancer	4.42e-05	0.000568	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—stomach cancer	4.41e-05	0.000567	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—stomach cancer	4.41e-05	0.000567	CcSEcCtD
Lamivudine—Hypersensitivity—Docetaxel—stomach cancer	4.39e-05	0.000564	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—stomach cancer	4.38e-05	0.000563	CcSEcCtD
Lamivudine—Confusional state—Methotrexate—stomach cancer	4.33e-05	0.000557	CcSEcCtD
Lamivudine—Loss of consciousness—Epirubicin—stomach cancer	4.33e-05	0.000556	CcSEcCtD
Lamivudine—Cough—Epirubicin—stomach cancer	4.3e-05	0.000553	CcSEcCtD
Lamivudine—Anaphylactic shock—Methotrexate—stomach cancer	4.3e-05	0.000552	CcSEcCtD
Lamivudine—Asthenia—Docetaxel—stomach cancer	4.28e-05	0.00055	CcSEcCtD
Lamivudine—Convulsion—Epirubicin—stomach cancer	4.27e-05	0.000549	CcSEcCtD
Lamivudine—Infection—Methotrexate—stomach cancer	4.27e-05	0.000549	CcSEcCtD
Lamivudine—Hypersensitivity—Capecitabine—stomach cancer	4.25e-05	0.000546	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—stomach cancer	4.23e-05	0.000544	CcSEcCtD
Lamivudine—Pruritus—Docetaxel—stomach cancer	4.22e-05	0.000542	CcSEcCtD
Lamivudine—Nervous system disorder—Methotrexate—stomach cancer	4.21e-05	0.000541	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—stomach cancer	4.21e-05	0.000541	CcSEcCtD
Lamivudine—Thrombocytopenia—Methotrexate—stomach cancer	4.21e-05	0.000541	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—stomach cancer	4.2e-05	0.000539	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—stomach cancer	4.2e-05	0.000539	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—stomach cancer	4.2e-05	0.000539	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—stomach cancer	4.18e-05	0.000537	CcSEcCtD
Lamivudine—Skin disorder—Methotrexate—stomach cancer	4.17e-05	0.000536	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	4.17e-05	0.000535	CcSEcCtD
Lamivudine—Hyperhidrosis—Methotrexate—stomach cancer	4.15e-05	0.000534	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—stomach cancer	4.15e-05	0.000533	CcSEcCtD
Lamivudine—Asthenia—Capecitabine—stomach cancer	4.14e-05	0.000532	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—stomach cancer	4.11e-05	0.000528	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—stomach cancer	4.1e-05	0.000527	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—stomach cancer	4.1e-05	0.000526	CcSEcCtD
Lamivudine—Anorexia—Methotrexate—stomach cancer	4.1e-05	0.000526	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—stomach cancer	4.09e-05	0.000525	CcSEcCtD
Lamivudine—Pruritus—Capecitabine—stomach cancer	4.08e-05	0.000525	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—stomach cancer	4.08e-05	0.000524	CcSEcCtD
Lamivudine—Diarrhoea—Docetaxel—stomach cancer	4.08e-05	0.000524	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—stomach cancer	4.06e-05	0.000521	CcSEcCtD
Lamivudine—Anaphylactic shock—Epirubicin—stomach cancer	4.02e-05	0.000517	CcSEcCtD
Lamivudine—Oedema—Epirubicin—stomach cancer	4.02e-05	0.000517	CcSEcCtD
Lamivudine—Hypotension—Methotrexate—stomach cancer	4.02e-05	0.000516	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—stomach cancer	4.01e-05	0.000515	CcSEcCtD
Lamivudine—Infection—Epirubicin—stomach cancer	4e-05	0.000513	CcSEcCtD
Lamivudine—Cough—Doxorubicin—stomach cancer	3.98e-05	0.000511	CcSEcCtD
Lamivudine—Shock—Epirubicin—stomach cancer	3.96e-05	0.000508	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—stomach cancer	3.95e-05	0.000508	CcSEcCtD
Lamivudine—Diarrhoea—Capecitabine—stomach cancer	3.95e-05	0.000508	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—stomach cancer	3.94e-05	0.000507	CcSEcCtD
Lamivudine—Dizziness—Docetaxel—stomach cancer	3.94e-05	0.000507	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—stomach cancer	3.94e-05	0.000506	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Methotrexate—stomach cancer	3.92e-05	0.000503	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—stomach cancer	3.91e-05	0.000502	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—stomach cancer	3.89e-05	0.0005	CcSEcCtD
Lamivudine—Insomnia—Methotrexate—stomach cancer	3.89e-05	0.000499	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—stomach cancer	3.88e-05	0.000499	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—stomach cancer	3.88e-05	0.000499	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—stomach cancer	3.88e-05	0.000499	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—stomach cancer	3.87e-05	0.000497	CcSEcCtD
Lamivudine—Paraesthesia—Methotrexate—stomach cancer	3.86e-05	0.000496	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	3.86e-05	0.000495	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—stomach cancer	3.84e-05	0.000493	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—stomach cancer	3.83e-05	0.000493	CcSEcCtD
Lamivudine—Dyspnoea—Methotrexate—stomach cancer	3.83e-05	0.000492	CcSEcCtD
Lamivudine—Somnolence—Methotrexate—stomach cancer	3.82e-05	0.000491	CcSEcCtD
Lamivudine—Dizziness—Capecitabine—stomach cancer	3.82e-05	0.00049	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—stomach cancer	3.8e-05	0.000488	CcSEcCtD
Lamivudine—Vomiting—Docetaxel—stomach cancer	3.79e-05	0.000487	CcSEcCtD
Lamivudine—Dyspepsia—Methotrexate—stomach cancer	3.78e-05	0.000486	CcSEcCtD
Lamivudine—Rash—Docetaxel—stomach cancer	3.76e-05	0.000483	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—stomach cancer	3.76e-05	0.000483	CcSEcCtD
Lamivudine—Dermatitis—Docetaxel—stomach cancer	3.76e-05	0.000483	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—stomach cancer	3.75e-05	0.000482	CcSEcCtD
Lamivudine—Decreased appetite—Methotrexate—stomach cancer	3.74e-05	0.00048	CcSEcCtD
Lamivudine—Headache—Docetaxel—stomach cancer	3.74e-05	0.00048	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—stomach cancer	3.72e-05	0.000478	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—stomach cancer	3.72e-05	0.000478	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Methotrexate—stomach cancer	3.71e-05	0.000477	CcSEcCtD
Lamivudine—Fatigue—Methotrexate—stomach cancer	3.71e-05	0.000476	CcSEcCtD
Lamivudine—Infection—Doxorubicin—stomach cancer	3.7e-05	0.000475	CcSEcCtD
Lamivudine—Pain—Methotrexate—stomach cancer	3.68e-05	0.000472	CcSEcCtD
Lamivudine—Vomiting—Capecitabine—stomach cancer	3.67e-05	0.000472	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—stomach cancer	3.66e-05	0.000471	CcSEcCtD
Lamivudine—Shock—Doxorubicin—stomach cancer	3.66e-05	0.00047	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—stomach cancer	3.65e-05	0.000469	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—stomach cancer	3.64e-05	0.000468	CcSEcCtD
Lamivudine—Rash—Capecitabine—stomach cancer	3.64e-05	0.000468	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—stomach cancer	3.64e-05	0.000467	CcSEcCtD
Lamivudine—Dermatitis—Capecitabine—stomach cancer	3.64e-05	0.000467	CcSEcCtD
Lamivudine—Headache—Capecitabine—stomach cancer	3.62e-05	0.000465	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—stomach cancer	3.61e-05	0.000464	CcSEcCtD
Lamivudine—Paraesthesia—Epirubicin—stomach cancer	3.61e-05	0.000464	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—stomach cancer	3.6e-05	0.000462	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—stomach cancer	3.59e-05	0.000461	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—stomach cancer	3.58e-05	0.000459	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—stomach cancer	3.55e-05	0.000456	CcSEcCtD
Lamivudine—Nausea—Docetaxel—stomach cancer	3.54e-05	0.000455	CcSEcCtD
Lamivudine—Feeling abnormal—Methotrexate—stomach cancer	3.54e-05	0.000455	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—stomach cancer	3.54e-05	0.000455	CcSEcCtD
Lamivudine—Gastrointestinal pain—Methotrexate—stomach cancer	3.51e-05	0.000452	CcSEcCtD
Lamivudine—Decreased appetite—Epirubicin—stomach cancer	3.5e-05	0.000449	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—stomach cancer	3.48e-05	0.000447	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—stomach cancer	3.47e-05	0.000446	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—stomach cancer	3.47e-05	0.000446	CcSEcCtD
Lamivudine—Pain—Epirubicin—stomach cancer	3.44e-05	0.000442	CcSEcCtD
Lamivudine—Constipation—Epirubicin—stomach cancer	3.44e-05	0.000442	CcSEcCtD
Lamivudine—Nausea—Capecitabine—stomach cancer	3.43e-05	0.000441	CcSEcCtD
Lamivudine—Urticaria—Methotrexate—stomach cancer	3.41e-05	0.000439	CcSEcCtD
Lamivudine—Abdominal pain—Methotrexate—stomach cancer	3.4e-05	0.000436	CcSEcCtD
Lamivudine—Body temperature increased—Methotrexate—stomach cancer	3.4e-05	0.000436	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.39e-05	0.000436	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—stomach cancer	3.37e-05	0.000432	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—stomach cancer	3.34e-05	0.000429	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—stomach cancer	3.32e-05	0.000426	CcSEcCtD
Lamivudine—Feeling abnormal—Epirubicin—stomach cancer	3.31e-05	0.000426	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—stomach cancer	3.31e-05	0.000425	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—stomach cancer	3.29e-05	0.000423	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—stomach cancer	3.28e-05	0.000421	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—stomach cancer	3.23e-05	0.000416	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—stomach cancer	3.21e-05	0.000413	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—stomach cancer	3.21e-05	0.000412	CcSEcCtD
Lamivudine—Urticaria—Epirubicin—stomach cancer	3.19e-05	0.000411	CcSEcCtD
Lamivudine—Pain—Doxorubicin—stomach cancer	3.18e-05	0.000409	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—stomach cancer	3.18e-05	0.000409	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—stomach cancer	3.18e-05	0.000408	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—stomach cancer	3.18e-05	0.000408	CcSEcCtD
Lamivudine—Hypersensitivity—Methotrexate—stomach cancer	3.17e-05	0.000407	CcSEcCtD
Lamivudine—Asthenia—Methotrexate—stomach cancer	3.08e-05	0.000396	CcSEcCtD
Lamivudine—Feeling abnormal—Doxorubicin—stomach cancer	3.07e-05	0.000394	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—stomach cancer	3.04e-05	0.000391	CcSEcCtD
Lamivudine—Pruritus—Methotrexate—stomach cancer	3.04e-05	0.000391	CcSEcCtD
Lamivudine—Hypersensitivity—Epirubicin—stomach cancer	2.96e-05	0.000381	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—stomach cancer	2.96e-05	0.00038	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—stomach cancer	2.94e-05	0.000378	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—stomach cancer	2.94e-05	0.000378	CcSEcCtD
Lamivudine—Diarrhoea—Methotrexate—stomach cancer	2.94e-05	0.000378	CcSEcCtD
Lamivudine—Asthenia—Epirubicin—stomach cancer	2.89e-05	0.000371	CcSEcCtD
Lamivudine—Pruritus—Epirubicin—stomach cancer	2.85e-05	0.000366	CcSEcCtD
Lamivudine—Dizziness—Methotrexate—stomach cancer	2.84e-05	0.000365	CcSEcCtD
Lamivudine—Diarrhoea—Epirubicin—stomach cancer	2.75e-05	0.000354	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—stomach cancer	2.74e-05	0.000352	CcSEcCtD
Lamivudine—Vomiting—Methotrexate—stomach cancer	2.73e-05	0.000351	CcSEcCtD
Lamivudine—Rash—Methotrexate—stomach cancer	2.71e-05	0.000348	CcSEcCtD
Lamivudine—Dermatitis—Methotrexate—stomach cancer	2.71e-05	0.000348	CcSEcCtD
Lamivudine—Headache—Methotrexate—stomach cancer	2.69e-05	0.000346	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—stomach cancer	2.67e-05	0.000343	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—stomach cancer	2.66e-05	0.000342	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—stomach cancer	2.63e-05	0.000338	CcSEcCtD
Lamivudine—Vomiting—Epirubicin—stomach cancer	2.56e-05	0.000329	CcSEcCtD
Lamivudine—Nausea—Methotrexate—stomach cancer	2.55e-05	0.000328	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—stomach cancer	2.55e-05	0.000327	CcSEcCtD
Lamivudine—Rash—Epirubicin—stomach cancer	2.54e-05	0.000326	CcSEcCtD
Lamivudine—Dermatitis—Epirubicin—stomach cancer	2.53e-05	0.000326	CcSEcCtD
Lamivudine—Headache—Epirubicin—stomach cancer	2.52e-05	0.000324	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—stomach cancer	2.46e-05	0.000316	CcSEcCtD
Lamivudine—Nausea—Epirubicin—stomach cancer	2.39e-05	0.000307	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—stomach cancer	2.37e-05	0.000304	CcSEcCtD
Lamivudine—Rash—Doxorubicin—stomach cancer	2.35e-05	0.000301	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—stomach cancer	2.34e-05	0.000301	CcSEcCtD
Lamivudine—Headache—Doxorubicin—stomach cancer	2.33e-05	0.0003	CcSEcCtD
Lamivudine—Nausea—Doxorubicin—stomach cancer	2.21e-05	0.000284	CcSEcCtD
Lamivudine—ABCB1—Metabolism—BLVRB—stomach cancer	5.41e-06	5.69e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—APOA1—stomach cancer	5.41e-06	5.69e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ENO1—stomach cancer	5.41e-06	5.69e-05	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—ALB—stomach cancer	5.41e-06	5.68e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—APOA1—stomach cancer	5.35e-06	5.62e-05	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CA—stomach cancer	5.31e-06	5.59e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALDOB—stomach cancer	5.26e-06	5.53e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SREBF2—stomach cancer	5.24e-06	5.51e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALDOB—stomach cancer	5.21e-06	5.47e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—MAPK1—stomach cancer	5.18e-06	5.44e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—RORA—stomach cancer	5.18e-06	5.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPAP2A—stomach cancer	5.16e-06	5.43e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CD44—stomach cancer	5.13e-06	5.39e-05	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—ALB—stomach cancer	5.08e-06	5.34e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.98e-06	5.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	4.96e-06	5.21e-05	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CA—stomach cancer	4.94e-06	5.19e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RPS6—stomach cancer	4.91e-06	5.16e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALOX5—stomach cancer	4.89e-06	5.14e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PPARG—stomach cancer	4.85e-06	5.1e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALDOB—stomach cancer	4.85e-06	5.1e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALOX5—stomach cancer	4.84e-06	5.09e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTT1—stomach cancer	4.83e-06	5.08e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—DPYD—stomach cancer	4.81e-06	5.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CD44—stomach cancer	4.8e-06	5.04e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP2A6—stomach cancer	4.78e-06	5.02e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—DPYD—stomach cancer	4.76e-06	5.01e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPP2R1A—stomach cancer	4.74e-06	4.99e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—APOA1—stomach cancer	4.71e-06	4.95e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—APOA1—stomach cancer	4.66e-06	4.9e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTP1—stomach cancer	4.65e-06	4.89e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKR1C3—stomach cancer	4.65e-06	4.89e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CKB—stomach cancer	4.6e-06	4.84e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA1—stomach cancer	4.6e-06	4.84e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NDUFA2—stomach cancer	4.6e-06	4.84e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FBP1—stomach cancer	4.6e-06	4.84e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—HMOX1—stomach cancer	4.59e-06	4.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	4.54e-06	4.77e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ENO1—stomach cancer	4.53e-06	4.76e-05	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CA—stomach cancer	4.52e-06	4.75e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALOX5—stomach cancer	4.51e-06	4.74e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HBEGF—stomach cancer	4.51e-06	4.74e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmission across Chemical Synapses—HRAS—stomach cancer	4.46e-06	4.69e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	4.46e-06	4.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	4.44e-06	4.67e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—DPYD—stomach cancer	4.44e-06	4.67e-05	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—ALB—stomach cancer	4.43e-06	4.65e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ALB—stomach cancer	4.36e-06	4.59e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPP2R1A—stomach cancer	4.36e-06	4.58e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—APOA1—stomach cancer	4.34e-06	4.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLIN2—stomach cancer	4.33e-06	4.55e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—TYMS—stomach cancer	4.33e-06	4.55e-05	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—ALB—stomach cancer	4.29e-06	4.51e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTP1—stomach cancer	4.28e-06	4.5e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—GSTM1—stomach cancer	4.28e-06	4.5e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—MAPK1—stomach cancer	4.26e-06	4.47e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTT1—stomach cancer	4.25e-06	4.47e-05	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—ALB—stomach cancer	4.24e-06	4.45e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—HMOX1—stomach cancer	4.22e-06	4.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CA2—stomach cancer	4.21e-06	4.43e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTT1—stomach cancer	4.21e-06	4.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	4.21e-06	4.42e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2A6—stomach cancer	4.21e-06	4.42e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—NOS3—stomach cancer	4.17e-06	4.39e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2A6—stomach cancer	4.16e-06	4.38e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmission across Chemical Synapses—HRAS—stomach cancer	4.16e-06	4.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NT5E—stomach cancer	4.1e-06	4.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PGAM1—stomach cancer	4.1e-06	4.31e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKR1C3—stomach cancer	4.09e-06	4.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PPP2R1A—stomach cancer	4.08e-06	4.29e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKR1C3—stomach cancer	4.05e-06	4.26e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—stomach cancer	4.05e-06	4.25e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ERCC2—stomach cancer	4.02e-06	4.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CD44—stomach cancer	4.02e-06	4.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	4.01e-06	4.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	4e-06	4.21e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ENO1—stomach cancer	3.99e-06	4.19e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—TYMS—stomach cancer	3.98e-06	4.18e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—MAPK1—stomach cancer	3.97e-06	4.17e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ENO1—stomach cancer	3.95e-06	4.15e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—GSTM1—stomach cancer	3.93e-06	4.13e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTT1—stomach cancer	3.92e-06	4.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLCE1—stomach cancer	3.91e-06	4.11e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDH7A1—stomach cancer	3.91e-06	4.11e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	3.9e-06	4.1e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.88e-06	4.08e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2A6—stomach cancer	3.88e-06	4.08e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK3—stomach cancer	3.83e-06	4.02e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTGS2—stomach cancer	3.82e-06	4.01e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.79e-06	3.98e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SMAD4—stomach cancer	3.79e-06	3.98e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—MTHFR—stomach cancer	3.78e-06	3.97e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKR1C3—stomach cancer	3.77e-06	3.97e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—UMPS—stomach cancer	3.75e-06	3.94e-05	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—ALB—stomach cancer	3.73e-06	3.92e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ERCC2—stomach cancer	3.7e-06	3.88e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—ALB—stomach cancer	3.69e-06	3.88e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ENO1—stomach cancer	3.68e-06	3.87e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—MAPK1—stomach cancer	3.64e-06	3.83e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FYN—stomach cancer	3.6e-06	3.78e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CD44—stomach cancer	3.54e-06	3.72e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CD44—stomach cancer	3.5e-06	3.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	3.5e-06	3.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PDHA1—stomach cancer	3.49e-06	3.67e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ECHS1—stomach cancer	3.49e-06	3.67e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CAV1—stomach cancer	3.49e-06	3.66e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—APOA1—stomach cancer	3.48e-06	3.66e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—MTHFR—stomach cancer	3.47e-06	3.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERCC2—stomach cancer	3.46e-06	3.63e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—KRAS—stomach cancer	3.44e-06	3.62e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—ALB—stomach cancer	3.44e-06	3.62e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CA—stomach cancer	3.42e-06	3.6e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Neuronal System—HRAS—stomach cancer	3.42e-06	3.59e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPP2R1A—stomach cancer	3.42e-06	3.59e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR2—stomach cancer	3.38e-06	3.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.36e-06	3.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—stomach cancer	3.35e-06	3.52e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	3.31e-06	3.48e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—HMOX1—stomach cancer	3.3e-06	3.47e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—FADS1—stomach cancer	3.28e-06	3.45e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMP—stomach cancer	3.28e-06	3.45e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CD44—stomach cancer	3.26e-06	3.43e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—stomach cancer	3.25e-06	3.42e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	3.22e-06	3.38e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CAV1—stomach cancer	3.2e-06	3.37e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—APOA1—stomach cancer	3.2e-06	3.36e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Neuronal System—HRAS—stomach cancer	3.19e-06	3.35e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—stomach cancer	3.16e-06	3.32e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	3.15e-06	3.31e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	3.15e-06	3.31e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TYMS—stomach cancer	3.12e-06	3.28e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IRS2—stomach cancer	3.09e-06	3.25e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—stomach cancer	3.08e-06	3.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SREBF2—stomach cancer	3.07e-06	3.23e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PPARG—stomach cancer	3.06e-06	3.22e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.06e-06	3.22e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—stomach cancer	3.06e-06	3.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—RORA—stomach cancer	3.03e-06	3.19e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPP2R1A—stomach cancer	3.01e-06	3.16e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	3e-06	3.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CAV1—stomach cancer	3e-06	3.15e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APOA1—stomach cancer	2.99e-06	3.14e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPP2R1A—stomach cancer	2.98e-06	3.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.97e-06	3.13e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—stomach cancer	2.95e-06	3.1e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—HRAS—stomach cancer	2.92e-06	3.07e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—stomach cancer	2.92e-06	3.07e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—HMOX1—stomach cancer	2.91e-06	3.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ERCC2—stomach cancer	2.9e-06	3.04e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—HMOX1—stomach cancer	2.88e-06	3.03e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALDOB—stomach cancer	2.84e-06	2.99e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6ST—stomach cancer	2.84e-06	2.99e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PPARG—stomach cancer	2.82e-06	2.96e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPP2R1A—stomach cancer	2.77e-06	2.92e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ALB—stomach cancer	2.76e-06	2.9e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMS—stomach cancer	2.74e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.73e-06	2.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—stomach cancer	2.73e-06	2.87e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—stomach cancer	2.72e-06	2.86e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—stomach cancer	2.72e-06	2.86e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMS—stomach cancer	2.71e-06	2.85e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—stomach cancer	2.71e-06	2.85e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—HMOX1—stomach cancer	2.68e-06	2.82e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—stomach cancer	2.68e-06	2.82e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALOX5—stomach cancer	2.64e-06	2.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.64e-06	2.78e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NOS3—stomach cancer	2.64e-06	2.77e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—DPYD—stomach cancer	2.6e-06	2.73e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ERCC2—stomach cancer	2.55e-06	2.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.54e-06	2.67e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6R—stomach cancer	2.54e-06	2.67e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ALB—stomach cancer	2.53e-06	2.66e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMS—stomach cancer	2.53e-06	2.66e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ERCC2—stomach cancer	2.52e-06	2.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAV1—stomach cancer	2.51e-06	2.64e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—APOA1—stomach cancer	2.5e-06	2.63e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—stomach cancer	2.5e-06	2.63e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NOS3—stomach cancer	2.42e-06	2.55e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—stomach cancer	2.41e-06	2.53e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.4e-06	2.52e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—stomach cancer	2.39e-06	2.52e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—stomach cancer	2.37e-06	2.5e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—stomach cancer	2.37e-06	2.49e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ERCC2—stomach cancer	2.35e-06	2.47e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—stomach cancer	2.35e-06	2.47e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—stomach cancer	2.3e-06	2.42e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—RHOA—stomach cancer	2.29e-06	2.41e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2A6—stomach cancer	2.27e-06	2.39e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS3—stomach cancer	2.27e-06	2.38e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—stomach cancer	2.22e-06	2.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1C3—stomach cancer	2.21e-06	2.33e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—stomach cancer	2.21e-06	2.32e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAV1—stomach cancer	2.21e-06	2.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARG—stomach cancer	2.21e-06	2.32e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—APOA1—stomach cancer	2.2e-06	2.32e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAV1—stomach cancer	2.19e-06	2.3e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—APOA1—stomach cancer	2.18e-06	2.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ENO1—stomach cancer	2.16e-06	2.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—stomach cancer	2.12e-06	2.23e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—stomach cancer	2.07e-06	2.18e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAV1—stomach cancer	2.04e-06	2.14e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—APOA1—stomach cancer	2.03e-06	2.14e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	2.02e-06	2.12e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ALB—stomach cancer	1.98e-06	2.09e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—stomach cancer	1.96e-06	2.06e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARG—stomach cancer	1.94e-06	2.04e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARG—stomach cancer	1.92e-06	2.02e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CD44—stomach cancer	1.91e-06	2.01e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NOS3—stomach cancer	1.9e-06	2e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—stomach cancer	1.81e-06	1.9e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARG—stomach cancer	1.79e-06	1.88e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ALB—stomach cancer	1.75e-06	1.84e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—stomach cancer	1.74e-06	1.83e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ALB—stomach cancer	1.73e-06	1.82e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NOS3—stomach cancer	1.67e-06	1.76e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NOS3—stomach cancer	1.65e-06	1.74e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.63e-06	1.71e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—stomach cancer	1.62e-06	1.7e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ALB—stomach cancer	1.61e-06	1.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—stomach cancer	1.59e-06	1.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HMOX1—stomach cancer	1.57e-06	1.65e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK3—stomach cancer	1.54e-06	1.62e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NOS3—stomach cancer	1.54e-06	1.62e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—stomach cancer	1.53e-06	1.61e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—stomach cancer	1.51e-06	1.59e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—stomach cancer	1.5e-06	1.58e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—stomach cancer	1.48e-06	1.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMS—stomach cancer	1.48e-06	1.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAPK1—stomach cancer	1.47e-06	1.55e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—stomach cancer	1.47e-06	1.54e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—stomach cancer	1.47e-06	1.54e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—stomach cancer	1.41e-06	1.48e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—stomach cancer	1.39e-06	1.46e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ERCC2—stomach cancer	1.38e-06	1.45e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—stomach cancer	1.36e-06	1.43e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—stomach cancer	1.29e-06	1.36e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—stomach cancer	1.28e-06	1.34e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAV1—stomach cancer	1.19e-06	1.26e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—APOA1—stomach cancer	1.19e-06	1.25e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HRAS—stomach cancer	1.18e-06	1.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—stomach cancer	1.13e-06	1.19e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—stomach cancer	1.07e-06	1.12e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARG—stomach cancer	1.05e-06	1.1e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ALB—stomach cancer	9.44e-07	9.92e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—stomach cancer	9.4e-07	9.88e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—stomach cancer	9.3e-07	9.78e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NOS3—stomach cancer	9.03e-07	9.49e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—stomach cancer	8.67e-07	9.11e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—stomach cancer	8.26e-07	8.68e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—stomach cancer	5.08e-07	5.34e-06	CbGpPWpGaD
